IF Holdco is not a vehicle for siphoning of our cash and IF Holdco pursues our pipeline, then this is a viable time table.
There is a clinical trial on-foot treating patients with a different form of dystrophy using the same method of delivery; AAV9 and direct injection but this is a gene therapy trial. This work is very relevant to ours. If I was on the management team, I would be offering to cooperate with the other scientists. Such cooperation could save a substantial amount of time for Benitec.
BLT Price at posting:
3.9¢ Sentiment: None Disclosure: Held
